Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Other Non Operating Income (2016 - 2022)

Historic Other Non Operating Income for Aptevo Therapeutics (APVO) over the last 8 years, with Q3 2022 value amounting to -$25000.0.

  • Aptevo Therapeutics' Other Non Operating Income rose 9892.57% to -$25000.0 in Q3 2022 from the same period last year, while for Dec 2022 it was $34.9 million, marking a year-over-year increase of 53572.68%. This contributed to the annual value of $37.2 million for FY2022, which is 56431.07% up from last year.
  • Latest data reveals that Aptevo Therapeutics reported Other Non Operating Income of -$25000.0 as of Q3 2022, which was up 9892.57% from $37.2 million recorded in Q2 2022.
  • Over the past 5 years, Aptevo Therapeutics' Other Non Operating Income peaked at $37.2 million during Q2 2022, and registered a low of -$2.6 million during Q4 2021.
  • Its 5-year average for Other Non Operating Income is $1.9 million, with a median of -$700000.0 in 2018.
  • In the last 5 years, Aptevo Therapeutics' Other Non Operating Income tumbled by 5865000.0% in 2021 and then soared by 168761.74% in 2022.
  • Over the past 5 years, Aptevo Therapeutics' Other Non Operating Income (Quarter) stood at -$700000.0 in 2018, then soared by 37.71% to -$436000.0 in 2019, then tumbled by 61.01% to -$702000.0 in 2020, then plummeted by 264.25% to -$2.6 million in 2021, then skyrocketed by 99.02% to -$25000.0 in 2022.
  • Its Other Non Operating Income was -$25000.0 in Q3 2022, compared to $37.2 million in Q2 2022 and -$2.3 million in Q1 2022.